Active Ingredients (In Each Extended Release Tablet)
Cetirizine HCl 5 mg
Pseudoephedrine HCl 120 mg
The following Structured Product Label (SPL) was submitted to the FDA by Rugby Laboratories for the product Rugby Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride (NDC 0536-1279). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients (in each extended release tablet), purpose, uses, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, stop use and ask a doctor if, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Cetirizine HCl 5 mg
Pseudoephedrine HCl 120 mg
Antihistamine
Nasal decongestant
taking tranquilizers or sedatives.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
|
|
|
|
|
|
|
|
colloidal silicon dioxide, hypromellose, lactose monohydrate, low-substituted hydroxypropyl cellulose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, talc, titanium dioxide
1-800-645-2158
Compare to Zyrtec-D® active ingredients
Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets
5 mg/120 mg
Antihistamine/Nasal Decongestant
Allergy and Congestion
Indoor and Outdoor Allergies
Actual Size
12 Hour Relief of:
Sneezing; Itchy, Watery Eyes;
Runny Nose; Itchy Throat or Nose;
Sinus Pressure; Nasal Congestion
12 Extended-Release Tablets
* Please review the disclaimer below.